3D-Printed Customized Endoprosthetic Reconstruction Following Resection of Metatarsal Malignancy: Case Series and Review of Reconstructive Strategies

医学 切除术 恶性肿瘤 第一跖骨 外科 系列(地层学) 普通外科 截骨术 病理 古生物学 生物
作者
Shangkun Tang,Chuang Li,Xin Hu,Zhuangzhuang Li,Linyun Tan,Hao Wang,Minxun Lu,Yi Luo,Yong Zhou,Chongqi Tu,Yitian Wang,Li Min
出处
期刊:Foot & Ankle International [SAGE Publishing]
标识
DOI:10.1177/10711007251355952
摘要

Malignant tumors of the metatarsals are relatively rare, presenting unique challenges in limb salvage surgery and functional reconstruction because of their critical role in weightbearing and foot biomechanics. This study aims to provide a basic assessment of the clinical outcomes of 3D-printed customized metatarsal endoprosthesis for the reconstruction of bone defects following the resection of metatarsal malignancy. This retrospective study analyzed 6 patients with malignant metatarsal tumors who underwent tumor resection and reconstruction using 3D-printed customized endoprostheses. The prostheses were designed based on CT and MRI data for precise anatomical adaptation and were fabricated using titanium alloy (Ti-6Al-4V) with a porous structure (70% porosity) to enhance osseointegration and mechanical stability. Outcomes were assessed using the visual analog scale (VAS), American Orthopaedic Foot & Ankle Society (AOFAS), and Musculoskeletal Tumor Society 93 (MSTS-93) score systems. Imaging modalities, including radiographs and Tomosynthesis-Shimadzu Metal Artefact Reduction Technology, were used to evaluate prosthesis integration and stability. All patients (range, 8-27 years) underwent wide-margin resections with no local recurrence or distant metastasis observed during a mean follow-up of 35 (range, 22-50) months. All lesions involved the first to third metatarsals, sparing the fourth and fifth. Postoperative improvements were observed in this small series, including a reduction in pain (VAS score 1), enhanced limb function (AOFAS score 88), and improved musculoskeletal functionality (MSTS-93 score 27). Imaging showed satisfactory bone-prosthesis integration without aseptic loosening or bone resorption. No major complications, such as infection, immune rejection, or mechanical failure, were observed, and all surgical wounds healed successfully. This case series provides early experience with 3D-printed metatarsal endoprostheses for reconstruction following tumor resection. The findings of this small series highlight the potential of 3D-printed prostheses to provide satisfactory functional outcomes, initial stability, and relatively few complications.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
HC3完成签到,获得积分10
刚刚
ziluolan007完成签到,获得积分10
刚刚
刚刚
刚刚
徐凤年完成签到,获得积分10
1秒前
GS_lly发布了新的文献求助30
1秒前
香蕉觅云应助山君采纳,获得10
1秒前
李治海完成签到,获得积分10
1秒前
1秒前
2秒前
2秒前
桐桐应助鹿茸采纳,获得10
2秒前
3秒前
CipherSage应助从容采纳,获得10
3秒前
3秒前
漫镜发布了新的文献求助10
3秒前
如沐春风发布了新的文献求助10
3秒前
肖肖发布了新的文献求助10
5秒前
莫言驳回了Lucas应助
5秒前
6秒前
cheng发布了新的文献求助10
6秒前
青黛发布了新的文献求助10
7秒前
caichengyu发布了新的文献求助10
7秒前
科研通AI5应助机智绝悟采纳,获得10
8秒前
Kirito发布了新的文献求助10
8秒前
8秒前
打打应助安好采纳,获得10
9秒前
9秒前
XXX完成签到 ,获得积分20
9秒前
10秒前
xquinn发布了新的文献求助10
10秒前
11秒前
12秒前
12秒前
liuzhanyu发布了新的文献求助10
12秒前
赘婿应助caichengyu采纳,获得10
12秒前
善学以致用应助caichengyu采纳,获得10
12秒前
000关注了科研通微信公众号
13秒前
13秒前
GS_lly完成签到,获得积分20
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Acute Mountain Sickness 2000
Handbook of Milkfat Fractionation Technology and Application, by Kerry E. Kaylegian and Robert C. Lindsay, AOCS Press, 1995 1000
The Social Work Ethics Casebook(2nd,Frederic G. R) 600
A novel angiographic index for predicting the efficacy of drug-coated balloons in small vessels 500
Textbook of Neonatal Resuscitation ® 500
The Affinity Designer Manual - Version 2: A Step-by-Step Beginner's Guide 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5073256
求助须知:如何正确求助?哪些是违规求助? 4293380
关于积分的说明 13378282
捐赠科研通 4114827
什么是DOI,文献DOI怎么找? 2253172
邀请新用户注册赠送积分活动 1257983
关于科研通互助平台的介绍 1190836